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Regulatory CD4 + T cells that express the transcription factor Foxp3 have an essential role in maintaining immune tolerance 1 . In the thymus, increased affinity for engagement of the T cell antigen receptor (TCR) by immature CD4 + single-positive thymocytes is required for the initiation of a program for the differentiation of regulatory T cells (T reg cells) and induction of Foxp3 expression 2 . As a consequence, T reg cells exported to the periphery exhibit a TCR repertoire skewed toward self-recognition 3, 4 . However, it remains unclear whether TCR signaling is needed to mediate the suppressive function of T reg cells in the periphery.
T reg cells exhibit impaired calcium flux, activation of the kinase Akt and phosphorylation of the kinase Erk upon TCR stimulation relative to that of conventional CD4 + T cells, and Foxp3 is known to potently repress at least some TCR-induced genes, as well as some genes encoding molecules involved in the TCR signaling pathway [5] [6] [7] [8] . At the same time, Foxp3 + T reg cells have high basal expression of several cell surface molecules that are known to contribute to T reg cell function (such as CD25, CD39 and CTLA-4), and the expression of these molecules in conventional CD4 + T cells is dependent upon TCR stimulation [9] [10] [11] [12] [13] [14] . It is not known whether high-affinity interactions of the TCR with complexes of self peptide and major histocompatibility complex (MHC) class II contribute to constitutive expression of these genes and, consequently, to T reg cell function.
T reg cells, despite their intrinsically dampened response to TCR stimulation, acquire an activated phenotype and expand their populations in response to their cognate antigens in settings of activation of the immune system, such as infection and autoimmunity 15, 16 . These observations indicate that recognition of self antigen helps maintain T reg cells of particular specificities and may potentiate their suppressive ability during immunological challenge 17 . Nevertheless, strict reliance on TCR expression for T reg cell activation, rather than 'preferential' activation of antigen-specific T reg cells, has not been demonstrated, nor has engagement of the TCR in vivo been shown to be required for T reg cell function in any context.
We used inducible genetic ablation of cell-surface TCR complexes to directly address the requirement for TCR expression in the immunosuppressive ability of T reg cells. Notably, the TCR was largely dispensable for Foxp3 expression, for lineage stability and for high expression of many signature genes in T reg cells. Nevertheless, these features were not sufficient to preserve T reg cell function or to prevent activation of the immune system. Loss of suppressor capacity in the absence of the TCR was not due to an impaired ability of T reg cells to gain access to interleukin 2 (IL-2) and, accordingly, administration of exogenous IL-2 failed to 'rescue' systemic autoimmunity. Instead, TCR expression was essential for the activation of T reg cells and for T reg cells to maintain expression of a limited set of genes found to be expressed almost exclusively in activated T reg cells. Among those genes, expression of the transcription factor IRF4 contributed to the optimal function and homeostasis of T reg cells. Our results demonstrate an essential role for the TCR in eliciting the suppressor function of differentiated T reg cells.
RESULTS

Maintenance of T reg cell identity in the absence of the TCR
To investigate the role of TCR signaling in T reg cell function, we crossed Trac FL mice (which have a loxP-flanked allele encoding the TCR α-chain constant region (C α or TCRα)) with Foxp3 eGFP-Cre-ERT2 mice (with expression of enhanced green fluorescent protein (eGFP) fused to a Cre recombinase-estrogen-receptor-ligand-binding-domain protein from the 3′ untranslated region of Foxp3; called 'Foxp3 Cre-ERT2 ' here) to achieve tamoxifen-inducible deletion of Trac specifically in T reg cells 18, 19 . In this model, Cre-induced loss of the conditional Trac allele upon tamoxifen administration eliminates TCRα expression, which prevents formation of heterodimers of TCRα and TCRβ (TCRαβ) at the cell surface. We administered tamoxifen via oral gavage on days 0 and 1 and analyzed mice on day 9. Allelic exclusion at the Trac locus in heterozygous Trac FL/WT Foxp3 Cre-ERT2 mice yielded a small population (25%) of TCR-deficient (as assessed by flow cytometry (TCRβ -; called 'TCR -' here)) T reg cells (~25%), whereas in homozygous Trac FL/FL Foxp3 Cre-ERT2 mice, the majority of T reg cells (~60-70%) lacked cell surface TCRβ (Fig. 1a) . Although we cannot definitively exclude the possibility that few residual TCR complexes were present in minute amounts (below the detection limit of flow cytometric analyses), functional in vitro analyses confirmed loss of TCR crosslinking-dependent activation of TCR − T reg cells ( Supplementary Fig. 1a-d) .
Because binding sites for the transcription factors NFAT and c-Rel have been identified in the Foxp3 locus, and because TCR engagementdriven signaling via the transcription factor NF-κB is critical for induction of Foxp3 expression, we speculated that the TCR might be essential for maintaining Foxp3 expression [20] [21] [22] . However, Foxp3 expression was reduced only marginally in TCR − T reg cells in Trac FL/WT Foxp3 Cre-ERT2 mice and was not reduced at all in TCR − T reg cells in Trac FL/FL Foxp3 Cre-ERT2 mice, relative to its expression in TCRexpressing (as assessed by flow cytometry (TCRβ + ; called 'TCR + ' here)) T reg cells in the same mice and in Trac WT/WT Foxp3 Cre-ERT2 mice (Fig. 1b) . Similarly, the expression of genes encoding several T reg cell signature molecules, including CD25, GITR, CD39 and CD73, was largely unaffected in TCR − T reg cells from both Trac FL/WT Foxp3 Cre-ERT2 and Trac FL/FL Foxp3 Cre-ERT2 mice ( Supplementary  Fig. 1e ). These results indicated that in the steady state, continuous TCR-mediated recognition of self did not contribute substantially to Foxp3-dependent maintenance of expression of these genes 11, 23 Fig. 1e) .
The frequency and absolute number of Foxp3 + cells in the spleens and lymph nodes of Trac FL/WT Foxp3 Cre-ERT2 and Trac FL/FL Foxp3 Cre-ERT2 mice were unaltered compared with that in Trac WT/WT Foxp3 Cre-ERT2 mice (Supplementary Fig. 1f) . However, to address the possibility that a portion of T reg cells completely lost Foxp3 expression upon ablation of the TCR and that these 'former' T reg cells were not accounted for in this experimental setup, we crossed Trac FL/WT Foxp3 Cre-ERT2 mice with mice that express the recombination reporter Rosa26 YFP (with sequence encoding yellow fluorescent protein (YFP) expressed form the ubiquitous Rosa26 locus). We assessed the expression (Fig. 1c) . Together these data indicated that TCR signaling was dispensable for the maintenance of the T reg cell phenotype and lineage stability and, moreover, that TCR signaling drove the loss of Foxp3 when IL-2 amounts were limiting.
Requirement for the TCR in effector differentiation of T reg cells Although the T reg cell phenotype was largely preserved upon ablation of the TCR, we observed relative enrichment for naive-like CD44 lo CD62L hi cells among TCR − T reg cells in lymph nodes and spleens of Trac FL/WT Foxp3 Cre-ERT2 and Trac FL/FL Foxp3 Cre-ERT2 mice ( Fig. 2a and Supplementary Fig. 1g ). T reg cell proliferation is restricted almost exclusively to the CD44 hi subset, and in part the enrichment we observed appeared to be a consequence of severely impaired proliferative capacity of CD44 hi T reg cells in the absence of the TCR 24 (Fig. 2b) . The small population of TCR − T reg cells in Trac FL/WT Foxp3 Cre-ERT2 mice was predominantly nondividing: these cells showed minimal expression of the proliferation marker Ki67, failed to incorporate the thymidine analog BrdU over a 24-hour labeling period and contained the greatest frequency of CD44 lo CD62L hi cells among all TCR + or TCR − T reg cell populations in Trac WT/WT Foxp3 Cre-ERT2 , Trac FL/WT Foxp3 Cre-ERT2 and Trac FL/FL Foxp3 Cre-ERT2 mice (Fig. 2a,b and Supplementary Fig. 1h ). In Trac FL/FL Foxp3 Cre-ERT2 mice, however, TCR − T reg cells exhibited considerable proliferative activity, albeit reduced relative to that of TCR + T reg cells present in the same mouse ( Fig. 2b and Supplementary Fig. 1h ). Increased Ki67 staining in CD44 hi T reg cells was inversely correlated with a lower frequency of CD44 lo CD62L hi cells among all TCR + or TCR − T reg cell populations in mice of all three genotypes (Fig. 2a,b) .
To address the possibility that continuous peripheral differentiation of naive-like T reg cells into CD44 hi cells was impeded in the absence of TCR expression and that such a differentiation block contributed to the Fig. 2c,d) .
Despite their generally intact T reg cell surface phenotype, nearly all TCR − T reg cells in healthy Trac FL/WT Foxp3 YFP-Cre mice had a naivelike CD62L hi CD44 lo phenotype and lacked expression of all T reg cell differentiation markers tested, including KLRG1, CD103 and CXCR3 ( Fig. 2c and data not shown) . Notably, we also observed this pattern under severe inflammatory conditions in Trac FL/FL Foxp3 YFP-Cre mice, which were moribund by 3 weeks of age ( Fig. 2c and Supplementary  Fig. 2e,f) . The lack of CD44 hi cells among TCR − populations in Trac FL/WT Foxp3 YFP-Cre and Trac FL/FL Foxp3 YFP-Cre mice correlated with the decreased proliferation and markedly diminished frequency and number of TCR − T reg cells relative to that of TCR + T reg cells in the same mice and in Trac WT/WT Foxp3 YFP-Cre mice; this pattern was evident in lymph nodes and was particularly pronounced in the spleen and other tissues such as the liver and lungs (Fig. 2d,e and Supplementary Fig. 2g,h ). Together these data were consistent with an absolute requirement for TCR expression, the loss of which could not be compensated for even in conditions of extreme activation of the immune system, for the peripheral effector differentiation of naive-like T reg cells and acquisition of an activated CD44 hi phenotype.
TCR-dependent effector function of mature T reg cells Foxp3 expression and T reg cell population expansion are facilitated by signaling via the receptor for IL-2 (IL-2R) [27] [28] [29] To more rigorously investigate the role of TCR expression in mature T reg cell function, we administered four doses of tamoxifen to mice (on days 0, 3, 7 and 10) to maximize Cre-ERT2-mediated recombination. On day 13, we noted loss of TCR expression in ~75-80% of T reg cells in Trac FL/FL Foxp3 Cre-ERT2 mice and ~25-30% of T reg cells in Trac FL/WT Foxp3 Cre-ERT2 mice (Fig. 3a,b) . Despite the normal or even increased frequency of total Foxp3 + cells in the lymph nodes and spleens of Trac FL/FL Foxp3 Cre-ERT2 mice, we found elevated numbers of CD4 + Foxp3 − and CD8 + T cells in the lymph nodes of these mice and a higher frequency of CD44 hi CD4 + and CD8 + T cells in their lymph nodes and spleens (Fig. 3c,d ). CD8 + T cells from Trac FL/FL Foxp3 Cre-ERT2 mice produced more interferon-γ (IFN-γ), and CD4 + T cells from these mice produced more IFN-γ, IL-2, IL-4, IL-13, IL-5 and IL-17, than did T cells from Trac WT/WT Foxp3 Cre-ERT2 and Trac FL/WT Foxp3 Cre-ERT2 mice ( Fig. 3e and data not shown). TCRβ 
A r t i c l e s
The activation of the immune system in Trac FL/FL Foxp3 Cre-ERT2 mice was milder than that resulting from complete depletion of T reg cells in Foxp3 DTR mice, which express the human diphtheria toxin receptor (DTR) concomitantly with Foxp3 (ref. 30 ). Thus, it was possible that the large number of TCR − T reg cells in Trac FL/FL Foxp3 Cre-ERT2 mice retained measurable TCR-independent suppressor ability and were still capable of immunoregulation. Alternatively, the small population of remaining TCR-sufficient T reg cells in these mice might have limited, to some degree, the activation of effector T cells and the associated autoimmunity. To examine these possibilities, we attempted to reduce the proportion of T reg cells among CD4 + cells in Foxp3 DTR mice to approximate the frequency of residual TCR-sufficient T reg cells in Trac FL/FL Foxp3 Cre-ERT2 mice following four doses of tamoxifen 31 . We reasoned that if TCR − T reg cells were capable of substantial suppression, autoimmunity in Foxp3 DTR mice subjected to only partial depletion of T reg cells would be more severe than that in Trac FL/FL Foxp3 Cre-ERT2 mice. Injection of diphtheria toxin depletes mice of T reg cells within 24 h, whereas tamoxifen-induced, Cre-ERT2-mediated recombination progressively increases over a 4-day period (data not shown). Therefore, we treated Foxp3 DTR , Trac WT/WT Foxp3 Cre-ERT2 and Trac FL/FL Foxp3 Cre-ERT2 mice with diphtheria toxin 4 d after their first dose of tamoxifen to account for the time needed for complete Cre-ERT2-mediated deletion of Trac (we administered both taximofen and diphtheria toxin to all genotypes; Supplementary  Fig. 3a,b) . Partial depletion of the T reg cell compartment in Foxp3 DTR mice resulted in activation and cytokine production of CD4 + Foxp3 − T cells grossly similar to that observed in Trac FL/FL Foxp3 Cre-ERT2 mice with populations of TCR-sufficient T reg cells of a similar or even larger size ( Supplementary Fig. 3b-d) . Together these results demonstrated that T reg cells required continuous TCR expression for the effective elaboration of their suppressor function, and suggested that TCR − T reg cells, which were abundant in Trac FL/FL Foxp3 Cre-ERT2 mice, were largely devoid of detectable suppressor ability.
TCR − T reg cell dysfunction is not secondary to impaired IL-2R signaling We considered that the apparent loss of suppressive ability of T reg cells in the absence of the TCR might be an indirect consequence of impaired ability to localize in a TCR-and antigen-dependent manner to sites of CD4 + T cell activation and to thereby acquire IL-2, a cytokine known to be critical for the function and homeostasis of T reg cells. This would explain the decreased expression of Foxp3 and minimal proliferation of TCR − T reg cells in healthy Trac FL/WT Foxp3 Cre-ERT2 mice, in which IL-2 amounts were not elevated and would not be able to partially remedy these defects 32 .
However, direct ex vivo analysis of phosphorylation of the transcription factor STAT5, which occurs downstream of IL-2 signaling in T reg cells, showed that in the spleen and lymph nodes of both Trac FL/WT Foxp3 Cre-ERT2 and Trac FL/FL Foxp3 Cre-ERT2 mice, the proportion of phosphorylated STAT5 in TCR − T reg cells was at least equivalent to that in TCR + T reg cells (Fig. 4a and data not shown) . In Trac FL/FL Foxp3 Cre-ERT2 mice, TCR − T reg cells had more phosphorylated STAT5 than did TCR + T reg cells; this mirrored their expression of CD25 and CD62L, which remained high on TCR − cells but was decreased on the residual activated TCR + T reg cells present in these mice (Figs. 2a and 4a and Supplementary Fig. 1e,g ). These results were consistent with the observation that T reg cells that contain phosphorylated STAT5 are found mainly in the CD62L hi CD44 lo (and CD25 hi ) subset of T reg cells; in contrast to the activated CD44 hi CD62L lo (and CD25 int ) T reg cell subset, this group of cells has been reported to rely on IL-2R signaling rather than engagement of costimulatory receptors for their maintenance 24 .
In vitro analysis confirmed that lack of TCR expression did not substantially influence the phosphorylation of STAT5 in response to IL-2, nor did it impair the ability of T reg cells to capture and deplete IL-2 from culture media (Supplementary Fig. 4a,b) , which suggested that in the absence of TCR expression, T reg cell-mediated deprivation of IL-2 might not be an important mechanism of immunosuppression. Furthermore, treatment of Trac WT/WT Foxp3 Cre-ERT2 , Trac FL/WT Foxp3 Cre-ERT2 and Trac FL/FL Foxp3 Cre-ERT2 mice with neutralizing antibody to IL-2 (anti-IL-2) or isotype-matched control antibody had a similar effect on TCR + and TCR − T reg cells, reducing Foxp3 expression and lowering the frequency of Foxp3 + cells among total CD4 + cells (Fig. 4b) . Together these data suggested that TCR − T reg cells efficiently captured IL-2 during activation of the immune system and at steady state. It remains to be determined what signal(s) drove Fig. 4c,d) .
Finally, the administration of complexes of IL-2 and anti-IL-2 to Trac FL/FL Foxp3 Cre-ERT2 mice did not measurably diminish the activation or lymphoproliferation of effector T cells caused by loss of TCR expression in T reg cells (Supplementary Fig. 5 ). Conversely, IL-2 depletion did not further exacerbate autoimmunity (data not shown). Notably, this was the case despite a 1.5-fold population expansion of TCR − T reg cells, but not of TCR + T reg cells, following IL-2 administration (probably a consequence of higher CD25 expression and heightened IL-2 responsiveness in TCR − T reg cells) and a reduction of over twofold in TCR − T reg cells following depletion of IL-2 ( Fig. 4b and Supplementary Fig. 5b ). These observations further confirmed that TCR − T reg cells, even when present in elevated numbers, had minimal suppressive ability. Together these results indicated that neither TCR-dependent interactions with antigen-presenting cells nor continuous TCR-mediated localization within lymphoid organs were required for T reg cells to acquire IL-2, and that T reg cell dysfunction in the absence of the TCR could not be attributed to altered IL-2R signaling.
TCR expression promotes T reg cell adhesive properties in vitro
The in vitro suppressive ability of T reg cells requires engagement of the TCR 33, 34 . This might involve pathways independent of the catalytic activity of the signaling kinase Zap70, which is essential for the effector function of conventional T cells, but dependent on membrane-proximal inside-out activation of integrins and subsequent enhancement of the interaction of T reg cells with antigen-presenting cells 8 Fig. 6a ). Conjugate formation was unaffected by the presence or absence of MHC class II molecules on DCs (Supplementary Fig. 6a ), which might indicate that the greater adhesion of TCR + T reg cells than of TCR − T reg cells in this assay was not a result of interactions between TCR and MHC class II and might have been a consequence of the overall heightened activation status of TCR + T reg cells relative to that of TCR − T reg cells. As expression of the integrin LFA-1 was higher on CD44 hi T reg cells than on CD44 lo CD62L hi T reg cells (Supplementary Fig. 6b) , it is possible that greater conjugate formation by TCR + T reg cells, which show greater enrichment for CD44 hi cells than do TCR − T reg cells, was due at least in part to increased expression of this integrin. Further work is needed to determine precisely how engagement of the TCR in vivo affects signaling pathways to modulate the adhesive properties of T reg cells. However, our results indicated that TCR expression contributed to optimal contact-dependent interactions between T reg cells and antigen-presenting cells, which might support TCR-dependent immunosuppressive function.
TCR modulation of the effector T reg cell transcriptional signature To explore whether TCR signals, apart from influencing T reg cell adhesion, might drive transcriptional events to 'license' suppressor function in vivo, we analyzed the gene expression of TCR + and TCR − T reg cells. Flow cytometry showed that loss of TCR expression had a stronger effect on effector-like CD44 hi CD62L lo T reg cells than on naive-like CD44 lo CD62L hi T reg cells (data not shown). This prompted us to investigate the gene-expression profiles of these two populations separately in the TCR + or TCR − T reg cell populations isolated from healthy Trac FL/WT Foxp3 Cre-ERT2 mice (to avoid confounding effects of activation of the immune system). We found that 155 genes were downregulated by at least twofold and only five genes were upregulated by that amount in effector-like CD44 hi CD62L lo TCR − T reg cells relative to their expression in CD44 hi CD62L lo TCR + T reg cells (Fig. 5a) . 16 (all of these were also downregulated in CD44 hi CD62L lo TCR − vs. CD44 hi CD62L lo TCR + T reg cells), whereas one gene was upregulated (Fig. 5a) . Some 535 genes showed higher expression (twofold or greater) in effector-like CD44 hi CD62L lo TCR + T reg cells than in naivelike CD44 lo CD62L hi TCR + T reg cells, and the expression of 136 of these (25%) was TCR dependent (Fig. 5b) . Notably, 127 of the 155 genes (82%) downregulated in the absence of the TCR in CD44 hi CD62L lo T reg cells showed at least twofold higher expression in effector-like T reg cells than in naive-like T reg cells (Fig. 5b) . Foxp3 has been proposed to solidify and amplify a transcriptional program initiated in T reg cell precursors by engagement of the TCR 9, 10, 35, 36 . We compared the expression of the 155 genes identified above as being maintained by the TCR in T reg cells (called 'TCRdependent genes' here) to the expression of Foxp3-dependent genes, identified as being upregulated in wild-type T reg cells relative to their expression in eGFP + T cells from Foxp3 GFP-KO mice, which express eGFP from a Foxp3-null allele 36 . We found that substantially more of the TCR-dependent genes than all genes were also Foxp3 dependent (Fig. 5c) . These observations suggested that the TCR-driven transcriptional program in T reg cells was enhanced by Foxp3 expression, but that Foxp3 alone was not sufficient to maintain the full transcriptional signature of effector T reg cells.
Examination of the TCR-dependent genes identified several transcription factors that were upregulated in TCR + CD44 hi CD62L lo T reg cells relative to their expression in TCR − CD44 hi CD62L lo , TCR + CD44 lo CD62L hi and TCR − CD44 lo CD62L hi T reg cells, including NFATc1, c-Rel, Bcl-6 and IRF4 (Fig. 5d) ; published data have shown that Bcl-6 and IRF4 are important for the differentiation and function of effector T reg cells [37] [38] [39] . Of the 155 TCR-dependent genes, we identified only one adhesion molecule-encoding gene (Vcam1) whose expression was upregulated in CD44 hi CD62L lo T reg cells relative to its expression in CD44 lo CD62L hi T reg cells in a manner that depended on TCR expression (Fig. 5d) . Genes encoding several other potential effector molecules were also upregulated in CD44 hi CD62L lo T reg cells relative to their expression in CD44 lo CD62L hi T reg cells, in a TCR-dependent manner, including those encoding IL-1R2 (a decoy receptor for IL-1); the immunoinhibitory molecules CD83, CD200 and LAG-3; IL-10; and EBI3 (a subunit of the cytokines IL-27 and IL-35) 26, [40] [41] [42] [43] [44] [45] . In addition, the chemokine-encoding genes Cxcl10 and Ccl1, as well as Ccr8 (which encodes the receptor for CCL1), were significantly downregulated in TCR − T reg cells relative to their expression in TCR + T reg cells, which suggested that T reg cells might signal each other through the expression of chemokines and their corresponding receptors or might recruit into close proximity the targets of their suppressive activity 46 . Together these data indicated that under physiological conditions, a substantial portion of the effector T reg cell transcriptional program, but not the naive-like T reg cell transcriptional program, characterized by elevated expression of several potential T reg cell effector molecules, was maintained by continuous TCR signaling.
IRF4 expression promotes T reg cell function and homeostasis
To begin to assess the importance of the TCR-dependent transcriptional program for continuous T reg cell function in vivo, we focused on IRF4 as a downstream target of the TCR signaling pathway in T reg cells. We confirmed that elevated IRF4 expression in T reg cells was restricted to CD44 hi cells and was reduced to basal expression upon ablation of the TCR in both Trac FL/WT Foxp3 Cre-ERT2 and Trac FL/FL Foxp3 Cre-ERT2 mice (Supplementary Fig. 7a ). Irf4 FL/− Foxp3 Cre-ERT2 mice, in which IRF4 is constitutively deleted in T reg cells, have been shown to develop severe autoimmunity dominated by type 2 helper T cell cytokines by 8 weeks of age 37 . T reg cells in Irf4 −/− mice have been shown to have an almost exclusively naive-like phenotype 38 , and we similarly found that T reg cells in Irf4 FL/FL Foxp3 YFP-Cre mice were largely CD44 lo CD62L hi , even in the context of severe inflammation (data not shown), which suggested impaired differentiation, survival and/or population expansion of effector T reg cells.
To (Fig. 6a) . We also saw higher GFP expression in the T reg cells, measured as a sum of fluorescence from the Irf4-deletion GFP reporter (whose expression is switched on in the Irf4 locus by Cre-mediated deletion of the Irf4 FL allele) and from the GFP-Cre-ERT2 fusion protein expressed concomitantly with Foxp3 ( Supplementary Fig. 7b ). Quantitative PCR analysis indicated ~50% lower abundance of Irf4 mRNA in T reg cells sorted from pooled spleens and lymph nodes of tamoxifen-treated Irf4 FL/FL Foxp3 Cre-ERT2 mice than in those of Irf4 WT/WT Foxp3 Cre-ERT2 mice (Fig. 6a) . We hypothesized that the suboptimal ~50% reduction in mRNA transcripts and the only slight reduction in IRF4 protein expression in the spleens and lymph nodes of Irf4 FL/FL Foxp3 Cre-ERT2 mice compared with that of Irf4 WT/WT Foxp3 Cre-ERT2 mice might have resulted from a competitive disadvantage of T reg cells that lack IRF4 protein. Such a disadvantage might lead to 'preferential' population expansion of the IRF4-sufficient T reg cells remaining in the Irf4 FL/FL Foxp3 Cre-ERT2 mice. This would be consistent with the published observation that the survival and expansion of strongly antigen-stimulated CD8 + T cells is greatly impaired in the absence of IRF4 (ref. 48) .
To determine whether IRF4 might similarly contribute to the maintenance of T reg cells that have been strongly activated, we assessed the colonic lamina propria, in which nearly all T reg cells were CD44 hi and had probably recently experienced engagement of the TCR, given their robust IL-10 production (data not shown). Indeed, we observed a lower frequency of colonic lamina propria T reg cells in Irf4 FL/FL Foxp3 Cre-ERT2 mice than in Irf4 WT/WT Foxp3 Cre-ERT2 mice (Fig. 6b) , similar to lower frequency of T reg cells in the colonic lamina propria of Trac FL/FL Foxp3 Cre-ERT2 mice than in Trac WT/WT Foxp3 Cre-ERT2 mice noted above. In contrast to spleen and lymph node T reg cells, and consistent with their lower frequency, colonic lamina propria T reg cells in Irf4 FL/FL Foxp3 Cre-ERT2 mice had much lower expression of IRF4 protein than did those in Irf4 WT/WT Foxp3 Cre-ERT2 mice (Fig. 6b) .
We hypothesized that the reportedly low influx of circulating T reg cells into the colonic lamina propria at steady state may have precluded IRF4-sufficient cells from becoming activated and repopulating to a wild-type frequency the T reg cell niche in this tissue 24 .
Despite the only slightly lower IRF4 expression in T reg cells isolated from the spleens and lymph nodes of Irf4 FL/FL Foxp3 Cre-ERT2 mice than in their counterparts from Irf4 WT/WT Foxp3 Cre-ERT2 mice, we were able to detect a very mild, but statistically significant, increase in the frequency of CD44 hi and Ki67 + lymph node Foxp3 − CD4 + T cells, as well as increased production of IFN-γ, IL-4 and IL-13 by splenic Foxp3 − CD4 + T cells (Fig. 6c,d ). This suggested that IRF4 expression downstream of TCR signaling in T reg cells contributed to the suppressive function of T reg cells. An increase in the production of type 2 helper T cell cytokines was consistent with the phenotype of mice with constitutive ablation of IRF4 in T reg cells, whereas the increased IFN-γ was probably a consequence of the substantial type 1 helper T cell bias in C56B/L6 adult mice before induced Irf4 deletion 37 .
As a control, we confirmed that in the absence of tamoxifen treatment, the expression of CD44, Ki67, IFN-γ, IL-4 and IL-13 in CD4 + Foxp3 − T cells from Irf4 FL/FL Foxp3 Cre-ERT2 mice was indistinguishable from that in their counterparts from Irf4 WT/WT Foxp3 Cre-ERT2 mice, as was the frequency of T reg cells in the colonic lamina propria (data not shown). This suggested that the modest differences between Irf4 FL/FL Foxp3 Cre-ERT2 and Irf4 WT/WT Foxp3 Cre-ERT2 mice that we observed upon tamoxifen treatment were not a consequence of the Irf4 FL allele itself. Together these data indicated that even partial loss of IRF4 expression downstream of TCR engagement in T reg cells interfered with optimal suppressive function of these cells. npg the TCR in T reg cell function in vivo has remained unclear. Here we demonstrated that TCR signaling in differentiated T reg cells was dispensable for the maintenance of Foxp3 expression and for the expression of many characteristic markers of T reg cells. Although the bulk of the T reg cell-specific gene signature was also preserved in the absence of the TCR, suppressor function was critically dependent on the TCR.
Given that antigen-activated CD4 + Foxp3 − T cells in lymphoid organs are thought to produce IL-2 in a spatially restricted manner, we considered the possibility that T reg cells might analogously require their TCRs to correctly position themselves to gain preferential access to IL-2. This might elicit the suppressive function of T reg cells by stimulating IL-2R. However, our in vivo and in vitro data suggested that T reg cells acquired and probably effectively depleted IL-2 in a TCR-independent manner. Thus, these cells may instead rely predominantly on expression of the chemokine receptor CCR7 to ensure sufficient IL-2 exposure, as has been proposed 24 .
Our observation that newly generated T reg cells in Trac FL/WT Foxp3 YFP-Cre and Trac FL/FL Foxp3 YFP-Cre mice remained naive-like upon loss of the TCR and did not populate nonlymphoid tissues suggested that effector differentiation and population expansion were processes dependent on the TCR and probably dependent on antigens. This finding may help explain the observation that distinct TCR repertoires are displayed by T reg cell populations in different lymphoid organs and tissues in adult mice 49, 50 . Furthermore, inducible ablation of the TCR resulted in a far greater change in gene expression in the effector-like T reg cell subset than in the naive-like subset. This suggested that continuous TCR signaling might be selectively driving the homeostasis and suppressor function of effector-like T reg cells. As inducible deletion of the TCR in differentiated T reg cells precipitated autoimmunity, our data may suggest that all or most of the suppressor function of T reg cells in vivo is mediated by the CD44 hi effector-like T reg cell subset.
We found that partial inducible ablation of Irf4, expressed downstream of TCR engagement in CD44 hi T reg cells, resulted in a very mild but reproducible activation of the immune system. This result suggested that IRF4 expression was important for TCR-dependent T reg cell function; however, given the suboptimal deletion of Irf4 and very modest activation of the immune system, it remains to be determined to what extent and in what way TCR-dependent induction of IRF4 in T reg cells contributes to their ability to suppress spontaneous autoimmunity. IRF4 may act mainly to control the maintenance of highly activated T reg cells, which was particularly evident in the colonic lamina propria and which, when altered, may affect the ability of the T reg cell pool to suppress. Alternatively, IRF4 may have a more direct role in promoting the suppressive activity of T reg cells, perhaps by driving the expression of certain T reg cell effector molecules. Although we observed decreased expression of the inducible costimulator ICOS on colonic T reg cells that lacked IRF4 (data not shown), the remaining IRF4-sufficient T reg cells in lymphoid organs of Irf4 FL/FL Foxp3 Cre-ERT2 mice preclude more rigorous identification of IRF4 targets.
However, we note that even though naive-like T reg cells did not express IRF4 and were overwhelmingly unaffected by TCR deletion on a transcriptional level, this did not necessarily indicate that these cells were nonfunctional or were not experiencing TCR engagement. Indeed, several genes, including Egr1, Egr2 and Nr4a1, were downregulated in this T reg cell subset in the absence of the TCR.
Additional experiments are needed to elucidate the contributions of other individual TCR-dependent genes in T reg cells to the maintenance of immunotolerance in the steady state and to the restraint of immune responses directed against commensal microorganisms, food and environmental antigens and pathogens. In connection with this, we note that although IL-10 production by T reg cells has been linked to the control of inflammatory responses at environmental interfaces such as the gut, lungs and skin, it has also been shown to be dispensable for T reg cell control over systemic autoimmunity 26 . Likewise, we found that whereas constitutive deletion of calcineurin B1 in Cnb1 FL/FL Foxp3 YFP-Cre mice (which eliminated calcineurin-dependent activation of NFAT in T reg cells) resulted in lethal early-onset autoimmunity, highly efficient inducible deletion in adult lymphoreplete Cnb1 FL/FL Foxp3 Cre-ERT2 mice had no detectable adverse effects on T reg cell function (data not shown). Together these findings suggest that engagement of the TCR on T reg cells may drive a focused transcriptional program, select aspects of which are required in a context-dependent manner for mediation of a broad range of T reg cell immunosuppressive functions.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. GEO: microarray data, GSE61077. 
ONLINE METHODS
Mice. Mice were bred and housed in the pathogen-free animal facility at Memorial Sloan-Kettering Cancer Center and were used in accordance with institutional guidelines. Unless otherwise noted, 8-to 10-week-old male and female sex-matched mice were used for all experiments. Foxp3 YFP-Cre , Foxp3 eGFP-Cre-ERT2 , Rosa26 YFP , Foxp3 DTR and Irf4 FL mice have been described 19, 26, 30, 47 . M. Schmidt-Supprian and K. Rajewsky provided Trac FL mice. For tamoxifen administration, 40 mg tamoxifen was dissolved in 100µl ethanol and subsequently in 900 µl olive oil (Sigma-Aldrich) and was sonicated four times for 30 s each in a Bioruptor Twin (Diagenode). Mice were given oral gavage of 200 µl tamoxifen emulsion per treatment. For injection of diphtheria toxin (DT), DT was dissolved in PBS and 200 µl of the appropriate dose was injected intraperitoneally into each mouse. For in vivo depletion of IL-2, mice were given tamoxifen by gavage on days 0 and 1 or on days 0, 3, 7 and 10 and were given intraperitoneal injection on days 4 and 8 of a 0.5mg 1:1 mixture of IL-2-neutralizing antibody (JES6-1A12 and S4B6-1; Bio X Cell) or IgG2a isotype-matched control antibody (Bio X Cell). For administration of IL-2-anti-IL2 complexes, 1 µg recombinant mouse IL-2 (R&D Systems) was incubated for 10 min at room temperature with 5 µg JES6-1 (Bio X Cell) and was diluted to a volume of 200 µl in PBS immediately before intraperitoneal injection. Mice were given tamoxifen by gavage on days 0, 3, 7 and 10 and received IL-2-anti-IL-2 complexes or PBS on days 5, 7, 9 and 11. No animals were excluded from analyses. No statistical method was used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments or outcome assessment.
Flow cytometry staining and cell isolation. Cells were stained with LIVE/ DEAD Fixable Yellow Dead Cell Stain (Molecular Probes) and antibodies listed in Supplementary Table 1 . For BrdU experiments, mice were given intraperitoneal injection of 1 mg BrdU (5-bromodeoxyuridine) in 1 ml PBS and cells were stained with a BD Pharmingen BrdU Flow Kit. An LSR II flow cytometer (BD Bioscience) and FlowJo software (TreeStar) were used for flow cytometry. For cell isolation, CD4 + T cells were purified from pooled spleen and lymph node cell suspensions with magnetic Dynabeads (Invitrogen) and were further sorted with a FACSAria II cell sorter (BD Bioscience). Intracellular staining was performed with eBioscience Fixation Permeabilization buffers. For cytokine staining, lymph node and spleen cells were stimulated for 4-6 h at 37 °C, 5% CO 2 , with soluble anti-CD3 (5 µg/ml; 2C11; Bio X Cell) and anti-CD28 (5 µg/ml; 37.51; Bio X Cell) in the presence of 1 µg/ml brefeldin A (Sigma).
In vitro proliferation assay. DC populations were expanded in vivo by subcutaneous injection of cytokine Flt3L-secreting B16 melanoma cells into the left hind flank of B6 mice. Once tumors were visible, spleens from injected mice were dissociated for 20 min at 37 °C, with shaking, in RPMI-1640 medium containing 1.67 units/ml Liberase TL (Roche) and 50 µg/ml DNase I (Roche). EDTA was added at a final concentration of 5 mM to stop digestion, and the resulting homogenate was processed for isolation of CD11c + cells with a MACS mouse CD11c (N418) purification kit (Miltenyi Biotec). CD4 + eGFP + cells purified by flow cytometry from tamoxifen-treated Trac FL/WT Foxp3 Cre-ERT2 mice were labeled with CellTrace Violet according to the manufacturer's instructions (Molecular Probes) and were plated in triplicate in 96-well flat-bottomed plates (5 × 10 4 cells per well) in medium containing 25 U/ml human recombinant IL-2 (PeproTech) with or without equal numbers of DCs and with or without 100 ng/ml LPS (Escherichia coli strain 0111:B4, Sigma-Aldrich).
In vitro IL-2 stimulation and detection of phosphorylated STAT5. Trac FL/WT Foxp3 Cre-ERT2 mice were treated with tamoxifen on days 0 and 1, and on day 9, CD4 + T cells were purified from pooled spleen and lymph node cell suspensions with magnetic Dynabeads (Invitrogen). Cells were stained with anti-CD4 (RM4-5; Tonbo Biosciences) and anti-TCRβ (H57-597; Tonbo Biosciences), then were washed and plated in 96-well V-bottomed plates (1 × 10 6 cells per well) in RPMI medium containing 10% FBS with or without increasing concentrations of IL-2, followed by incubation for 20 min at 37 °C. Cells were subsequently processed with BD Phosflow Lyse/Fix Buffer and Perm Buffer III (BD Biosciences) and were stained with antibody to STAT5 phosphorylated at Tyr694 (47/Stat5; BD Biosciences) according to the manufacturer's instructions. T reg cells were identified by eGFP expression. For ex vivo staining of phosphorylated STAT5, spleen and lymph nodes were dissociated at 4 °C in PBS (0.5% BSA) containing anti-CD4 and anti-TCRβ (both identified above), were stained for 10 min on ice and were washed twice before fixation.
In vitro depletion of IL-2. Trac FL/WT Foxp3 Cre-ERT2 mice were treated with tamoxifen on days 0 and 1, and on day 9, pooled spleens and lymph nodes were enriched for CD4 + cells and subsequently sorted to a purity of >99% into eGFP + TCRβ + , eGFP + TCRβ − and eGFP − TCRβ + populations. Each population was divided among eight wells of a 96-well V-bottomed plate (2.5 × 10 5 cells/well) in 25 ul RPMI medium (10%) with or without increasing doses of recombinant human IL-2, followed by incubation for 2 h at 37 °C. Depletion of IL-2 from the medium was assessed with the BD Cytometric Bead Array and Human IL-2 Enhanced Sensitivity Flex Set according to the manufacturer's instructions (BD Biosciences).
In vitro conjugation assay. Trac WT/WT Foxp3 Cre-ERT2 , Trac FL/WT Foxp3 Cre-ERT2 and Trac FL/FL Foxp3 Cre-ERT2 mice were treated with tamoxifen on days 0 and 1, and on day 9, CD4 + T cells were isolated from spleen and lymph nodes with the Dynabeads Untouched Mouse CD4 Cells negative selection kit (Invitrogen.) TCR + T reg cells were sorted from Trac WT/WT Foxp3 Cre-ERT2 mice on the basis of eGFP expression alone. TCR − T reg cells were sorted from Trac FL/WT Foxp3 Cre-ERT2 and Trac FL/FL Foxp3 Cre-ERT2 mice as eGFP + TCRβ − cells. T reg cells were subsequently labeled with CFSE (carboxyfluorescein diacetate succinimidyl ester), and populations of DCs from mice with no deficiency or homozygous deficiency in MHC class II were expanded in vivo with Flt3L-secreting B16 melanoma cells and were labeled with CellTrace Violet. 1 × 10 4 T reg cells and 6 × 10 4 DCs were cultured together in a 96-well round-bottomed plate in RPMI medium 10% supplemented with 500 U/ml IL-2. Concanavalin A (C2010; Sigma) was used at a final concentration of 2.5 µg/ml. Following 10 h of culture at 37 °C, cells were gently resuspended before flow cytometry.
Gene-expression analysis. eGFP + TCRβ + and TCRβ − CD44 hi CD62L lo cell populations (two replicates) and CD44 lo CD62L hi cell populations (three replicates) were sorted from tamoxifen-treated Trac FL/WT Foxp3 Cre-ERT2 mice (five or more mice per replicate) with a FACSAria II flow cytometer. Complementary DNA (cDNA) libraries were amplified and hybridized to Affymetrix 430 2.0 chips. Arrays were normalized by the robust multiarray average method, and genes were considered to have a difference in expression if they had a q value of <0.01 after Benjamini-Hochberg false-discovery rate correction. Differences in gene expression in T reg cells from Foxp3 GFPKO mice and Foxp3 + mice has been described 36 . npg
